I125 irradiation stent for treatment of hepatocellular carcinoma with portal vein thrombosis: A meta-analysis.

CONCLUSION: I125 irradiation stent seems to be more effective in treating hepatocellular carcinoma with portal vein tumor thrombosis. The usage of portal vein stent combined endovascular brachytherapy has the potential to act as an alternative therapy for HCC with PVTT. On account of the limitation of studies included, more studies with high-level evidence, such as RCTs, are requisite to support the above promising results. PMID: 33455874 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33455874?dopt=Abstract

Source: Cancer Radiotherapie - January 14, 2021 Category: Cancer & Oncology Authors: Li S, Guo JH, Lu J, Wang C, Wu H, Wang H, Zha J, Fan R Tags: Cancer Radiother Source Type: research